The procalcitonin kinetics paradox in hemoadsorption therapy for septic shock: Infection source, immunomodulation, and biomarker reliability
Turkish Journal of Intensive Care · 21.06.2026 · 24 (2) · 159-161
DOI: 10.63729/tjic.2026.694 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Intensive Care, online erschienen am 21.06.2026. Verfasst von Hüseyin İflazoğlu und 1 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
İflazoğlu, H., & İnal, V. (2026). The procalcitonin kinetics paradox in hemoadsorption therapy for septic shock: Infection source, immunomodulation, and biomarker reliability. Turkish Journal of Intensive Care, 24(2), 159-161. https://doi.org/10.63729/tjic.2026.694
Vancouver
İflazoğlu H, İnal V. The procalcitonin kinetics paradox in hemoadsorption therapy for septic shock: Infection source, immunomodulation, and biomarker reliability. Turkish Journal of Intensive Care. 2026;24(2):159-161. doi:10.63729/tjic.2026.694
BibTeX
@article{flazolu2026,
author = {İflazoğlu, Hüseyin and İnal, Volkan},
title = {The procalcitonin kinetics paradox in hemoadsorption therapy for septic shock: Infection source, immunomodulation, and biomarker reliability},
journal = {Turkish Journal of Intensive Care},
year = {2026},
volume = {24},
number = {2},
pages = {159--161},
doi = {10.63729/tjic.2026.694}
}
EUVIMED